Cardiologia
Atualização do consenso de especialistas sobre a classificação SCAI SHOCK do choque cardiogênico.
4 Fev, 2022 | 15:14hComunicado de imprensa: SCAI releases updated expert consensus to SCAI SHOCK classification – Society for Cardiovascular Angiography and Interventions
Comentários:
SCAI SHOCK: Update Refines Cardiogenic Shock Classification – TCTMD
SCAI Releases Updated Expert Consensus to SCAI SHOCK Classification – American College of Cardiology
Comentários no Twitter
.@SCAI SHOCK stage is an indication of shock severity & comprises one component of mortality risk prediction in pts w/ CS, along w/ etiology/phenotype & other risk modifiers; a 3-axis model of risk stratification in CS has been proposed. Learn more: https://t.co/tnh2JFhHzN #JACC pic.twitter.com/yK2ye9wcd0
— JACC Journals (@JACCJournals) January 31, 2022
SCAI SHOCK Stage Classification Expert Consensus Update released today in the inaugural issue of @MyJSCAI and also in @JACCJournals. Thank you to endorsing societies @ACCinTouch @american_heart @ACEPNow @escardio @ACVCPresident @ISHLT @SCCM @STS_CTsurgery https://t.co/GHrYn5I5WO pic.twitter.com/Y0mKC0zONu
— SCAI Now (@SCAI) January 31, 2022
M-A | Vasopressina e glicocorticoides na parada cardíaca em pacientes internados.
4 Fev, 2022 | 14:56hConteúdo relacionado: RCT: Vasopressin + Methylprednisolone increase the likelihood of return of spontaneous circulation compared to placebo in patients with in-hospital cardiac arrest.
Comentário no Twitter
Systemic review and meta analysis post VAM-IHCA.
▶️ Moderate certainty for benefit with steroids and vasopressin on ROSC
▶️ Less certainty for longer term outcomes @mathiasholmb@LarsWAndersen1 @AsgerGranfeldthttps://t.co/K3jZ1gBs1h— Critical Care Reviews (@CritCareReviews) January 4, 2022
Revisão sistemática | Mudança na frequência cardíaca em repouso e risco para mortalidade por todas as causas.
4 Fev, 2022 | 14:55h
Comentário no Twitter
What's the resting heart rate? How does it change? To keep in mind: there may be a correlation w all-cause mortality. Check the #EJPC paper of the week by @WDerman @m_heine01 et al. https://t.co/fCq0NxIx4v#CVPrev #EAPC_ESC #heart @m_piepoli @SilCastelletti @paolo_emilio pic.twitter.com/xJn2nbmPLS
— European Society of Cardiology Journals (@ESC_Journals) January 30, 2022
Revisão | Tratamento do risco de doença cardiovascular aumentado após desfechos adversos de gestação.
4 Fev, 2022 | 14:40hPrimary Care–Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review – Journal of General Internal Medicine (se o acesso a este link for pago, tente este)
Ver também: thread from the author on Twitter summarizing the article
Conteúdos relacionados:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
Cohort Study: Cardiovascular Disease After Hypertensive Disorders of Pregnancy Largely Explained by Conventional Cardiovascular Risk Factors (estudos recentes sobre o tema)
Um estudo de registro na Dinamarca encontrou um risco aumentado de sangramento com a associação de fluconazol sistêmico e apixabam (OR 3,5; 95% IC, 1,4-10,6).
4 Fev, 2022 | 14:26hPosicionamento científico | Prevenção da insuficiência cardíaca.
31 Jan, 2022 | 09:04hMiocardite após vacinação de adolescentes com BNT162b2 em Israel.
31 Jan, 2022 | 08:55hMyocarditis after BNT162b2 Vaccination in Israeli Adolescents – New England Journal of Medicine
Conteúdos relacionados:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Comentário no Twitter
Data from the Israeli MOH show estimates of myocarditis risk in the 21 days after a first & second dose of vaccine were 0.56 per 100,000 and 8.09 per 100,000 among male recipients and 0 per 100,000 and 0.69 per 100,000 among females. https://t.co/M6kxVA2toS pic.twitter.com/bQ4TBmcrj4
— NEJM (@NEJM) January 29, 2022
Revisão sistemática | Dietas com baixo carboidrato vs. dietas com carboidrato equilibrado para redução de peso e de risco cardiovascular.
31 Jan, 2022 | 08:49h
Comentário no Twitter
Low carbohydrate diets or balanced‐carbohydrate diets: which works better for weight loss & heart disease risks? https://t.co/gFcGUpYKyT
There's probably little to no difference between them in terms of their effects on:
🍽️ amount of weight people lose
❤️ heart disease risks pic.twitter.com/g5IxTC1mKz— Cochrane UK (@CochraneUK) January 30, 2022
M-A | Inibidores do SGLT-2 e desfechos cardiovasculares em pacientes com e sem histórico de insuficiência cardíaca.
31 Jan, 2022 | 08:28h
Comentário no Twitter
SGLT-2 inhibitors improve CV outcomes irrespective of heart failure history and LVEF: a meta-analysis of RCTs https://t.co/QPRCzT9olH#EHJPharmacotherapy #cardiotwitter @AgewallStefan @GianluSava pic.twitter.com/sESFn7Fdxg
— European Society of Cardiology Journals (@ESC_Journals) January 29, 2022
Revisão | Síndromes geriátricas em idosos submetidos a intervenções cardiovasculares.
31 Jan, 2022 | 08:21h
Comentário no Twitter
The rapidly growing older adult population is frequently affected by a multitude of geriatric- or age-associated conditions that influence cardiovascular outcomes collectively known as, geriatric syndromes. Read more: https://t.co/LFQRwD2rqj #ACCGeriatric #cvGeri @DrDamluji
— American College of Cardiology (@ACCinTouch) January 28, 2022


